In our MI-RISK consortium, consisting of 4 internationally recognized research groups, it is our ambition to bridge the knowledge gap between AMI and SCD to improve survival of AMI patients. Inclusion of complementary research groups with expertise’s spanning from patient to animal model to molecular biology to computer simulation underpins a synergistic approach to discover risk factors and causes of SCD during AMI.

 

 

Consortium

 

Jacob Tfelt-Hansen,Clinical Research Associate Professor, Staff Cardiologist, DMSc, Department of Cardiology,
Copenhagen University Hospital, Rigshospitalet

 

Thomas Jespersen, Associate Professor, PhD, DMSc,Department of Biomedical Sciences, University of Copenhagen

 

 

Christine M. Albert Director of the Center for Arrhythmia Prevention at the Brigham and Women’s Hospital and Professor at Harvard Medical School

 

Molly Maleckar Director of the Simula School of Research and Innovation at Simula Research Laboaratory

 

Hermenegild

 

 

 

Funded by Novo Nordic foundation

 

 

 

 

 

 

 

 

 

© 2015 MI-RISK CONSORTIUM